Aug 19, 2019

Farmak is the leader in the pharmaceutical industry of Ukraine according to the results of the first half of 2019

The State Statistics Service of Ukraine published data on industrial production for 6 months of 2019. Over this period, the country’s overall industrial production index grew by only 0.5% (compared with the first half of last year), but the pharmaceutical industry was notable for its positive dynamics. The production index of pharmaceutical products and preparations amounted to 10.7% increase, while exports increased by 30.5% in the first 5 months of the year.

State Statistic’s Service data is also confirmed by other surveys – according to the pharmaceutical market research conducted by SMD, the market grew by 11% in the first quarter of 2019, and 5 companies are the leaders in the retail segment – Farmak (with a share of 5.7%),  Arterium (3.8%), Sanofi (3.5%), Darnitsa (3.3%) and Novartis Group (2.9%).

According to the PharmXplorer / Pharmstandard study of Proxima Research for the first half of 2019, in money terms, sales of all pharmacy products increased by 16.6% compared to the same period last year – up to UAH 48.9 billion. For the eighth consecutive year, the leader is Farmak, which increased sales in money terms by 18% and has a market share of 5.42%, followed by Arterium Corporation with sales growth of 11.7% and a market share of 3.44%. The third position is occupied by Darnitsa, which increased sales by 13.7% and has market share of 3.19%.

Back to the News